Biotech Maven
Top Stories
FDA Calendar & Milestone Watch
Trading Ideas
Trending News
  1. Biotech Maven
  2. Trending News

Good piece on how successfully new biotech ventures are capturing venture capital money. These…

Biotech Maven

VC money booms in Q2, with mega-deals hitting record levels
VC money booms in Q2, with mega-deals hitting record levels

If it wasn’t clear from the firehose of financing deals we’ve covered over the past few months, it’s now official: VC activity is booming in healthcare, with Q2 drawing in $5.1 billion in capital. That’s 22% of the total $23 billion raised by all VC-backed companies in the US, according

Comments

Trending News

FEATURED
COMMUNITY

Two Notable Analyst Calls For Monday Afternoon, July 16th

A quick synopsis of two notable analyst calls that could move the following small biotech concerns late in the day

Biotech Maven

Add This 'Arrow' To Your Investment 'Quiver'

Why simple options strategies should be embraced by biotech investors

Biotech Maven

Two Notable Analyst Calls For Thursday Afternoon, July 12th

A quick synopsis of two notable analyst calls that could move the following small biotech concerns late in the day

Biotech Maven

Two Notable Late Analyst Calls For Wednesday, July 11th

A quick synopsis of two notable analyst calls that could move the following small biotech concerns late in the day

Biotech Maven

Two Notable Late Analyst Calls For Monday, July 2nd

A quick synopsis of two notable analyst calls that could move the following small biotech concerns late in the day

Biotech Maven

Two Notable Analyst Calls For Thursday, June 28th

A quick synopsis of two notable analyst calls that could move the following small biotech concerns

Biotech Maven

Two Notable Analyst Calls For Tuesday, June 26th

A quick synopsis of two notable analyst calls that could move the following small biotech concerns

Biotech Maven

Pharma Advertising Continues To Go Digital

Biotech and pharma concerns continue to move the bulk of their advertising to digital platforms

Biotech Maven